Blueprint Medicines Statistics
Total Valuation
BNY Mellon has a market cap or net worth of $72.08 billion. The enterprise value is -$61.54 billion.
Important Dates
The last earnings date was Tuesday, July 15, 2025, before market open.
| Earnings Date | Jul 15, 2025 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
BNY Mellon has 705.24 million shares outstanding. The number of shares has decreased by -4.58% in one year.
| Current Share Class | 705.24M |
| Shares Outstanding | 705.24M |
| Shares Change (YoY) | -4.58% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 89.90% |
| Float | 703.53M |
Valuation Ratios
The trailing PE ratio is 15.63 and the forward PE ratio is 13.89. BNY Mellon's PEG ratio is 0.95.
| PE Ratio | 15.63 |
| Forward PE | 13.89 |
| PS Ratio | 3.85 |
| Forward PS | 3.54 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 4.43 |
| P/FCF Ratio | 30.29 |
| P/OCF Ratio | 18.74 |
| PEG Ratio | 0.95 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 32.17 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.68%.
| Return on Equity (ROE) | 11.68% |
| Return on Assets (ROA) | 1.09% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $372,027 |
| Profits Per Employee | $92,278 |
| Employee Count | 51,800 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BNY Mellon has paid $1.36 billion in taxes.
| Income Tax | 1.36B |
| Effective Tax Rate | 21.31% |
Stock Price Statistics
The stock price has increased by +64.35% in the last 52 weeks. The beta is 1.12, so BNY Mellon's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | +64.35% |
| 50-Day Moving Average | 94.03 |
| 200-Day Moving Average | 84.64 |
| Relative Strength Index (RSI) | 68.97 |
| Average Volume (20 Days) | 4,312,140 |
Short Selling Information
The latest short interest is 9.93 million, so 1.41% of the outstanding shares have been sold short.
| Short Interest | 9.93M |
| Short Previous Month | 9.17M |
| Short % of Shares Out | 1.41% |
| Short % of Float | 1.41% |
| Short Ratio (days to cover) | 1.96 |
Income Statement
In the last 12 months, BNY Mellon had revenue of $19.27 billion and earned $4.78 billion in profits. Earnings per share was $6.54.
| Revenue | 19.27B |
| Gross Profit | 19.27B |
| Operating Income | 6.64B |
| Pretax Income | 4.41B |
| Net Income | 4.78B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $6.54 |
Full Income StatementBalance Sheet
The company has $210.18 billion in cash and $76.56 billion in debt, giving a net cash position of $133.62 billion or $189.47 per share.
| Cash & Cash Equivalents | 210.18B |
| Total Debt | 76.56B |
| Net Cash | 133.62B |
| Net Cash Per Share | $189.47 |
| Equity (Book Value) | 44.54B |
| Book Value Per Share | 54.76 |
| Working Capital | -175.85B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.85 billion and capital expenditures -$1.47 billion, giving a free cash flow of $2.38 billion.
| Operating Cash Flow | 3.85B |
| Capital Expenditures | -1.47B |
| Free Cash Flow | 2.38B |
| FCF Per Share | $3.37 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | 34.47% |
| Pretax Margin | 32.99% |
| Profit Margin | 25.84% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 12.35% |
Dividends & Yields
This stock pays an annual dividend of $2.12, which amounts to a dividend yield of 2.07%.
| Dividend Per Share | $2.12 |
| Dividend Yield | 2.07% |
| Dividend Growth (YoY) | 12.14% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 29.67% |
| Buyback Yield | 4.58% |
| Shareholder Yield | 6.65% |
| Earnings Yield | 6.63% |
| FCF Yield | 3.30% |
Dividend DetailsAnalyst Forecast
The average price target for BNY Mellon is $94.38, which is -7.66% lower than the current price. The consensus rating is "Buy".
| Price Target | $94.38 |
| Price Target Difference | -7.66% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 3.82% |
| EPS Growth Forecast (5Y) | 11.81% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on July 1, 2007. It was a reverse split with a ratio of 1:1.06.
| Last Split Date | Jul 1, 2007 |
| Split Type | Reverse |
| Split Ratio | 1:1.06 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
